Showing items 1 - 6 of 6

Your selections:

Transdiagnostic internet-delivered cognitive-behaviour therapy (CBT) for adults with functional gastrointestinal disorders (FGID): A feasibility open trial

- Dear, B. F., Fogliati, V. J., Fogliati, R., Gandy, M., McDonald, S., Talley, N., Holtmann, G., Titov, N., Jones, M.

A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia

- Rich, G., Shah, A., Koloski, N., Funk, P., Stracke, B., Köhler, S., Holtmann, G.

The validity of a new structured assessment of gastrointestinal symptoms scale (SAGIS) for evaluating symptoms in the clinical setting

- Koloski, N. A., Jones, M., Talley, N. J., Holtmann, G., Hammer, J., von Wulffen, M., Shah, A., Hoelz, H., Kutyla, M., Burger, D., Martin, N., Gurusamy, S. R.

Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures

- Shanahan, E. R., Zhong, L., Talley, N. J., Morrison, M., Holtmann, G.

Investigating the intestinal mucosa-associated microbiota – relevance and potential pitfalls: authors’ reply (letter)

- Shanahan, E. R., Zhong, L., Talley, N. J., Morrison, M., Holtmann, G.

A preliminary analysis of the effect Iberogast, Nexium, dual Iberogast + Nexium or dual placebo on symptoms in patients with functional dyspepsia

- Pilichiewicz, A. N., Andrews, J. M., Goess, C., McMahon, J., Fraser, R. J., Beilby, J., Holloway, R. H., Talley, N. J., Holtmann, G.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit